Transdermal delivery of allopurinol to acute hyperuricemic mice <i>via</i> polymer microneedles for the regulation of serum uric acid levels

Polymer microneedle patches for transdermal delivery of anti-hyperuricemia drugs (Allopurinol, AP) have been developed for regulating serum uric acid levels, reducing adverse reactions and improving the bioavailability of AP.